Apalutamide/Lestaurtinib CAS 111358-88-4 Raw Powder

CAS: 111358-88-4

MF: C26H21N3O4

Specification​: 99% min Apalutamide/Lestaurtinib Powder

Sample:  Apalutamide/Lestaurtinib Powder

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

Apalutamide/Lestaurtinib Powder Usage and Synthesis:

Apalutamide Powder is a medication used in the treatment of prostate cancer. It is classified as an androgen receptor inhibitor, which means it blocks the action of male hormones (androgens) in the body, including testosterone. By blocking androgen receptors, Apalutamide Raw Powder helps to slow the growth and spread of prostate cancer cells.

Apalutamide is typically used in combination with other treatments for prostate cancer, such as surgery, radiation therapy, or chemotherapy. It is also used in men with non-metastatic castration-resistant prostate cancer, which means the cancer continues to grow despite low levels of testosterone in the body.

Common side effects of apalutamide include fatigue, nausea, diarrhea, decreased appetite, and high blood pressure. It may also cause liver problems, so regular liver function tests are required while taking this medication.

Apalutamide is available only with a prescription from a healthcare provider and should only be used under medical supervision.

Pharmacokinetics of Apalutamide/Lestaurtinib Powder:

Letatinib is a semi-synthetic, orally bioavailable receptor tyrosine kinase inhibitor that has shown therapeutic efficacy in the treatment of diseases such as acute myeloid leukemia, chronic myeloid leukemia and acute lymphoblastic leukemia.

Applications of Apalutamide/Lestaurtinib Powder:

Letatinib, a multi-targeted indole and carbazole derivative, effectively inhibits FLT3 autophosphorylation in vitro and is the most widely studied drug in clinical trials to date. Multiple late-stage trials are currently underway to study this drug in adult and pediatric leukemias.